New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
08:58 EDTDDD, CTSH, OMER, DATA, VJET, MRK, XONE, SSYS, RL, COCOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Merck (MRK), up 1.6%... Ralph Lauren (RL), up 7%... Tableau Software (DATA), up 12%... Corinthian Colleges (COCO), up 2%. ALSO HIGHER: Omeros (OMER), up 11% after granted fast track designation to OMS824 by FDA. DOWN AFTER EARNINGS: Allergan (AGN), down xx%... Cognizant (CTSH), down 5%. ALSO LOWER: 3D Systems (DDD), down 15% after lowering FY13 EPS view, guiding FY14 below estimates. Peers Stratasys (SSYS), down 7.5%, ExOne (XONE), down 8%, and Voxeljet (VJET), down 7%, lower as well.
News For DDD;RL;SSYS;XONE;MRK;VJET;DATA;OMER;CTSH;COCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 26, 2014
17:07 EDTCOCOCorinthian receives CID from DoJ over grade manipulation, seeks more liquidity
Subscribe for More Information
08:31 EDTMRKLigand, Merck receive approval for NOXAFIL
Subscribe for More Information
07:34 EDTXONEKei Advisors to hold a conference
Western New York Investors Conference to be held in Buffalo, New York on September 26.
September 25, 2014
14:01 EDTXONE, VJET, SSYS, DDDAutodesk provides details on previously reported 3D plans, 3DPrint.com says
Subscribe for More Information
September 24, 2014
07:33 EDTSSYSStratasys acquisition should bring cross-selling opportunities, says RBC Capital
Subscribe for More Information
September 23, 2014
16:54 EDTVJETNovel Century Ventures liquidates passive stake in Voxeljet
Subscribe for More Information
11:42 EDTSSYS, DDD, VJET, XONE 3D Systems rises after analyst reports 'unexpected' GM deal
Subscribe for More Information
11:04 EDTDDD3D Systems jumps 3% after Piper says deal landed with GM
11:03 EDTDDD3D Systems landed $6M-$8M deal with GM, says Piper Jaffray
Piper Jaffray says that based on conversations with industry contacts, it believes 3D Systems (DDD) landed an unexpected deal with General Motors (GM) in Q3. Piper thinks the Bluebird deal could be in the range of $6M-$8M. The firm believes the deal was not in 3D's pipeline. It has a Neutral rating on the stock.
08:08 EDTSSYSStratasys completes acquisition of GrabCAD
Subscribe for More Information
07:33 EDTMRKOphthotech names Michael Atieh as EVP, Chief Financial and Business Officer
Ophthotech Corporation (OPHT) announced that Michael G. Atieh has been named EVP, Chief Financial and Business Officer and Treasurer effective September 30. Atieh replaces Bruce A. Peacock, Chief Financial and Business Officer and Treasurer, who has notified the company of his intention to retire effective September 30. Atieh spent the majority of his career in the pharmaceutical industry with Merck and Co (MRK), where he held various senior level positions over a 20 year period including Senior Vice President-Merck Medco Managed Care, Vice President-U.S. Human Health, Vice President-Public Affairs, Vice President-Government Relations, and Treasurer.
September 22, 2014
11:03 EDTSSYSUPS expands 3D printing across U.S. with Stratasys collaboration
UPS (UPS) is expanding 3D printing services to meet the growing demands of its small business customers to nearly 100 additional locations nationwide. As the first nationwide retailer to offer 3D printing services in-store, in collaboration with Stratasys (SSYS), the UPS Store continues to evolve its services to better meet the needs of small business owners.
06:51 EDTMRKMerck to host conference call
Subscribe for More Information
06:12 EDTDDDStocks with implied volatility below IV index mean; QIHU DDD
Stocks with implied volatility below IV index mean; Qihoo 360 (QIHU) 41, 3D Systems (DDD) 39 according to iVolatility.
September 19, 2014
17:40 EDTCOCOCorinthian Colleges received grand jury subpoena on September 3
On September 3, the company received a grand jury subpoena for documents from the United States Attorney’s Office in the Middle District of Florida. The subpoena seeks documents and records relating to an internal investigation of a former employee’s misconduct at the Everest Brandon campus and the company’s return of Title IV funds as a result of the investigation. The company initially self-reported the results of the internal investigation to the Office of Inspector General for the Department of Education on June 28, 2013. It is not clear whether the subpoena seeks this information regarding the former employee, the company or both. The company is evaluating the subpoena and intends to cooperate fully with the request. On September 10, the company received a grand jury subpoena for documents from the United States Attorney’s Office in the Northern District of Georgia. The subpoena seeks documents and records relating to the Everest Jonesboro and Everest Decatur campuses regarding matters including job placement, graduation rates, admissions, attendance, and student and employee information. The grand jury subpoena is signed by the same assistant United States attorney that assisted with the original, April 11, 2011 civil investigative demand for similar documents related to the same two campuses. The company is evaluating the subpoena and intends to cooperate fully with the request. On September 15, the company received a letter from the Accrediting Commission of Career Schools and Colleges, or ACCSC, the institutional accrediting agency for forty campuses, notifying the company that it was placing the Corinthian system of schools on “Warning,” continuing the company’s schools on Employment Verification Reporting, continuing to review the materials and responses submitted by the company regarding all outstanding matters both within ACCSC and externally, directing the company’s ACCSC schools to inform current and prospective students that it is on Warning, placing Corinthian’s schools on Financial Reporting, and restricting the company’s schools from applying for certain substantive changes.
10:21 EDTDDD3D Systems shares compelling into quarter's end, says Canaccord
Subscribe for More Information
September 18, 2014
08:48 EDTMRKNeogen's dairy genomic program to be marketed by Merck
Subscribe for More Information
September 17, 2014
17:09 EDTXONENovel Century Ventures reduces passive stake in ExOne to 9.68% from 15.46%
Subscribe for More Information
09:33 EDTMRKMerck announced positive results from Phase 3 data for omarigliptin
Subscribe for More Information
08:31 EDTMRKMerck, Sun Pharma enter into licensing agreement for Tildrakizumab
Merck and Sun Pharmaceutical Industries, through their respective subsidiaries,announced an exclusive worldwide licensing agreement for Merck’s investigational therapeutic antibody candidate, tildrakizumab, which is currently being evaluated in Phase 3 registration trials for the treatment of chronic plaque psoriasis, a skin ailment. Under terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of $80M. Merck will continue all clinical development and regulatory activities, which will be funded by Sun Pharma. Upon product approval, Sun Pharma will be responsible for regulatory activities, including subsequent submissions, pharmacovigilance, post approval studies, manufacturing and commercialization of the approved product. Merck is eligible to receive undisclosed payments associated with regulatory and sales milestones, as well as tiered royalties ranging from mid-single digit through teen percentage rates on sales. The transaction is subject to customary closing conditions, including the requirements under the Hart Scott-Rodino Antitrust Improvements Act.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use